Bausch+Lomb | Results Presentation Deck | 41 slides

Bausch + Lomb · 2022-06
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

41
every slide · same image gating as the playbook
01
Slide 1
front_matter
04
front_matter
05
establish_context
Open slide detailBeat · Problem
06
summarize
Open slide detailBeat · Problem
07
The slide uses a four-column layout to present key performance indicators and strategic updates.summarize
Open slide detailBeat · Problem
08
Includes a bar chart for total revenue, three donut charts for segment/geographic splits, and a table-like layout for organic growth drivers.analyze_data
Open slide detailBeat · Financials
09
Includes footnotes regarding non-GAAP measures and specific market impacts.analyze_data
Open slide detailBeat · Financials
10
Includes GAAP financial data with reported, constant currency, and organic change metrics.analyze_data
Open slide detailBeat · Financials
11
The slide explains a specific negative impact on cash flow from operations due to intercompany settlement timing.analyze_data
Open slide detailBeat · Financials
12
transition
13
Includes footnotes regarding non-GAAP measures, interest expense details, and forward-looking statement disclaimers.analyze_data
14
The slide uses two side-by-side waterfall charts to explain the bridge between 2021 actuals and 2022 guidance.analyze_data
15
transition
Open slide detailBeat · SolutionLoop · Cost Of Inaction
16
The chart shows a clear trend of LUMIFY overtaking Visine and other competitors since 1Q18.analyze_data
Open slide detailBeat · SolutionLoop · Cost Of Inaction
17
Uses a three-column layout: Problem (left), Solution (center), and Validation (right).present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
18
Includes clinical trial data (PEACHTREE study) and market sizing context.summarize
Open slide detailBeat · SolutionLoop · Cost Of Inaction
19
Data presented for the MOJAVE study at Day 57.analyze_data
Open slide detailBeat · SolutionLoop · Cost Of Inaction
20
The slide uses a timeline-based layout to map product launches against market opportunity metrics.size_opportunity
Open slide detailBeat · SolutionLoop · Cost Of Inaction
21
The slide highlights market opportunities for Femto Cataract Laser, LASIK Flap Laser, and a 202X Combined System.size_opportunity
22
The diagram uses concentric circles to represent the breadth of the company's reach.present_framework
24
The chart highlights Bausch + Lomb's growth relative to competitors.compare_peers
Open slide detailBeat · Market Size
25
plan_implementation
26
plan_implementation
27
summarize
28
analyze_data
29
analyze_data
30
analyze_data
31
The slide provides a bridge between GAAP and non-GAAP financial metrics.analyze_data
32
The table reconciles GAAP operating income to non-GAAP figures by adding back items like amortization, impairments, and restructuring costs.analyze_data
33
Standard financial reconciliation table for non-GAAP metrics.analyze_data
34
The table includes adjustments for exchange rates, divestitures, and discontinuations to arrive at non-GAAP organic revenue figures.analyze_data
36
Page number 35 is visible in the bottom right corner.appendix
37
This slide provides the qualitative justification for financial adjustments, specifically focusing on separation-related costs and litigation/settlement expenseappendix
39
Standard financial disclosure slide for non-GAAP reconciliations.appendix
40
Standard financial disclosure slide explaining the methodology and utility of non-GAAP metrics.appendix